SAGE

Clinical Medicine Insights Therapeutics Template

Write in a clean editor, then format for Clinical Medicine Insights Therapeutics in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Clinical Medicine Insights Therapeutics format

Clinical Medicine Insights Therapeutics is a peer-reviewed journal published by SAGE, covering Asthma and respiratory diseases, Diabetes Treatment and Management, Chronic Lymphocytic Leukemia Research.

PublisherSAGE
Reference styleAuthor–year (Harvard)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical Medicine Insights Therapeutics, 12(3), pp. 45–58.

Formats any DOI in Clinical Medicine Insights Therapeutics style. No sign-up.

Publishes research inAsthma and respiratory diseases Diabetes Treatment and Management Chronic Lymphocytic Leukemia Research Atrial Fibrillation Management and Outcomes Neuroscience and Neuropharmacology Research
ISSN1179-559X
h-index15
i10-index28
Total citations1,035
Open accessYes
Top institutions publishing hereCreighton University
Journal websitewww.la-press.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Clinical Medicine Insights Therapeutics per year

87
2010
44
2011
22
2012
13
2013
4
2014
8
2015
10
2016
23
2017
4
2018
2
2019

Citation impact of Clinical Medicine Insights Therapeutics by publication year

359
2010
159
2011
53
2012
139
2013
5
2014
33
2015
122
2016
147
2017
13
2018
2
2019

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Clinical Medicine Insights Therapeutics

Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck

Kelsey P. Pendleton, Jennifer R. Grandis · 1 Jan 2013

Recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) is a devastating malignancy with a poor prognosis. Treatment is limited to chemotherapeutic approaches. Cisplatin is an established and effective treatment for R/M HNSCC, and many studies have investigated cisplatin treatment in combination with other agents. Even when being treated with first line therapy…

Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options

Bubu A. Banini, Arun J. Sanyal · 1 Jan 2016

Nonalcoholic fatty liver disease (NAFLD) is on the rise and has become a major etiology for chronic liver disease. It is frequently associated with obesity, insulin resistance, hypertension, and dyslipidemia and is considered the hepatic manifestation of metabolic syndrome. In this review, we present a summary of the epidemiology and pathogenesis of NAFLD, and discuss…

Sirolimus Eluting Stents

Patrick Hu, Ehtisham Mahmud · 1 Jan 2010

The sirolimus-eluting stent (SES) Cypher was the first commercially available drug-eluting stent. The use of this stent has resulted in significantly lower rates of restenosis and lesion revascularization compared to bare metal stents and balloon angioplasty. In this review, angiographic and clinical outcomes in patients treated with SES are compared to those treated with bare…

Incidence and Risk Factors of Surgical Site Infection Among Patients Undergoing Cesarean Section

Hanan Hussein Jasim, Syed Azhar Syed Sulaiman, Amer Hayat Khan et al. · 1 Jan 2017

Background: Wound infections constitute a significant problem in surgical procedures. In cesarean sections (CS), this is particularly important as a wound infection not only results in increased morbidity but also has far-reaching implications by way of pelvic organ disease, disturbance of the bonding process between mother and baby in the puerperium, and a longer hospital…

Donepezil: A Review of Pharmacological Characteristics and Role in the Management of Alzheimer Disease

Vesna Jelić, Taher Darreh‐Shori · 1 Jan 2010

Donepezil is a potent, selective, noncompetitive, and rapidly reversible inhibitor of acetylcholinesterase (AChEI) licensed for the treatment of Alzheimer disease (AD); and is the first and only AChEI licensed for the treatment of severe AD. Its efficacy as monotherapy, or in combination with the NMDA-agonist, memantine, has been documented in several randomised double-blind, placebo-controlled, short-term…

Clinical Medicine Insights Therapeutics template — frequently asked questions

How do I write a paper in the Clinical Medicine Insights Therapeutics format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Clinical Medicine Insights Therapeutics template. When you export, DocuGuru compiles the paper into the official SAGE format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Clinical Medicine Insights Therapeutics use?
Clinical Medicine Insights Therapeutics uses Author–year (Harvard) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical Medicine Insights Therapeutics, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to Clinical Medicine Insights Therapeutics?
No. DocuGuru generates the sagej LaTeX class and compiles the PDF for you in the background, so you get a SAGE-ready Clinical Medicine Insights Therapeutics document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Clinical Medicine Insights Therapeutics template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Clinical Medicine Insights Therapeutics format with correct headings, figures, tables, and author–year citations.
Who publishes Clinical Medicine Insights Therapeutics?
Clinical Medicine Insights Therapeutics is a multidisciplinary journal published by SAGE. DocuGuru's Clinical Medicine Insights Therapeutics template matches SAGE's official submission format.
Can I export a submission-ready Clinical Medicine Insights Therapeutics PDF?
Yes — DocuGuru produces a PDF built with the official Clinical Medicine Insights Therapeutics template (the sagej class) that is ready to submit to SAGE, together with the matching LaTeX source files.
How much does the Clinical Medicine Insights Therapeutics template cost?
You can start writing in the Clinical Medicine Insights Therapeutics template for free. Exporting the final submission-ready Clinical Medicine Insights Therapeutics PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Clinical Medicine Insights Therapeutics template